EM Imaging at EIE16

23 May 2016 | Events

On 12th May, EM Imaging took part to the EIE16 investor showcase (http://www.eie-invest.com/), along with 60 companies across the Life Sciences, Energy and ICT sectors. With more than 900 guests, the event was an absolute success. EM Imaging had the opportunity to...

Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

7 Apr 2016 | Collaborations, Press Releases

Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical...

Edinburgh Molecular imaging Ltd awarded Innovate UK grant to qualify the role of EMI-137 in colorectal cancer lesion detection

9 Mar 2016 | Collaborations, EMI-137

Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the UK Infrastructure Phase I grant from the UK’s innovation agency, Innovate UK. The SBRI grant aims to accelerate and increase the...

EM Imaging finalist at Pitch@Palace

26 Feb 2016 | Awards, Events

EM Imaging has been selected  as one of the 14 teams that will Pitch on Monday 7th March, 2016 at St. James’s Palace. In addition, there will be a Peoples Choice vote and we would appreciate if our followers could vote for us at the...

Edinburgh Molecular Imaging to Pitch@Palace

21 Feb 2016 | Events

Edinburgh Molecular Imaging have been announced as finalists at the Duke of York’s ‘Pitch at the Palace’ competition, which is designed to help entrepreneurs develop their business ideas. The team  will pitch to HRH Duke of York and 300...